We are excited to announce our upcoming webinar in collaboration with Beacon for rare diseases and Cures Within Reach!

Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data, AI can help identify existing medicines that might work for different conditions – something particularly valuable in rare diseases.

However, do AI-generated predictions actually work when tested in real-life clinical trials?

Cures Within Reach is helping to explore this question through a new funding call. They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas, with a preference for rare disease!

You can visit https://bit.ly/cwrrfps for more information.

In this webinar, we’ll cover:

• A breakdown of what this funding call is about
• Advice from Cures Within Reach on what makes a strong application
• How patient groups can get involved in applications
• A practical example of a patient group contributing to an AI-led initiative
• The opportunity to ask any questions you might have to the Cures Within Reach team

If you’d like to learn more, please visit Beacon’s website!

To get your ticket, click here.

Who is this webinar for?

This session is open to any patient group interested in learning more about this unique funding opportunity – including patient groups already involved in AI-driven clinical research, as well as those looking to better understand how AI can support drug repurposing.

No technical AI experience is needed – the session is designed to be accessible regardless of where you are on your journey!